CSF1/CSF1R signaling is critical to macrophage proliferation and fibrogenesis in murine models of cGVHD-BOS (19), and in humans, the CSF1R inhibitor axatilimab recently received regulatory approval for steroid refractory cGVHD (109). Here, CSF1 is linked to Buschke-Ollendorff syndrome.